Alternative binding proteins: affibody binding proteins developed from a small three-helix bundle scaffold

The FEBS Journal
Per-Ake Nygren

Abstract

In recent years, classical antibody-based affinity reagents have been challenged by novel types of binding proteins developed by combinatorial protein engineering principles. One of these classes of binding proteins of non-Ig origin are the so-called affibody binding proteins, functionally selected from libraries of a small (6 kDa), non-cysteine three-helix bundle domain used as a scaffold. During the first 10 years since they were first described, high-affinity affibody binding proteins have been selected towards a large number of targets for use in a variety of applications, such as bioseparation, diagnostics, functional inhibition, viral targeting and in vivo tumor imaging/therapy. The small size offers the possibility to produce functional affibody binding proteins also by chemical synthesis production routes, which has been found to be advantageous for the site-specific introduction of various labels and radionuclide chelators.

References

Feb 1, 1987·Protein Engineering·B NilssonM Uhlén
Jun 1, 1995·Protein Engineering·K NordP A Nygren
Mar 26, 1998·FEMS Immunology and Medical Microbiology·B JanssonP A Nygren
Feb 2, 1999·Journal of Molecular Biology·L Lo ConteJ Janin
May 7, 1999·Immunotechnology : an International Journal of Immunological Engineering·M HanssonP A Nygren
Nov 11, 1999·Protein Engineering·E GunneriussonP Nygren
Feb 28, 2002·Journal of Immunological Methods·Jenny RönnmarkPer-Ake Nygren
Jun 6, 2002·European Journal of Biochemistry·Jenny RönnmarkPer-Ake Nygren
Nov 30, 2002·Angewandte Chemie·Hening Lin, Virginia W Cornish
Feb 21, 2003·Proceedings of the National Academy of Sciences of the United States of America·Elisabet WahlbergTorleif Härd
Feb 27, 2003·Proceedings of the National Academy of Sciences of the United States of America·Martin HögbomPär Nordlund
Oct 29, 2003·Journal of Immunological Methods·Jenny RönnmarkPer-Ake Nygren
Nov 26, 2003·Journal of Biotechnology·Olof NordPer-Ake Nygren
Jun 23, 2004·Protein Engineering, Design & Selection : PEDS·M WikmanS Ståhl
Jul 21, 2004·Journal of Immunological Methods·Per-Ake Nygren, Arne Skerra
Oct 7, 2004·Analytical Biochemistry·Björn RenbergAmelie Eriksson Karlström
May 10, 2005·Chembiochem : a European Journal of Chemical Biology·Torun EngfeldtAmelie Eriksson Karlström
Sep 10, 2005·Nature Biotechnology·Philipp Holliger, Peter J Hudson
Oct 8, 2005·Nature Biotechnology·H Kaspar BinzAndreas Plückthun
Apr 19, 2006·Cancer Research·Anna OrlovaFredrik Y Nilsson
May 17, 2006·Journal of Molecular Biology·Jakob DoganTorleif Härd
May 23, 2006·Biotechnology and Applied Biochemistry·Maria WikmanStefan Ståhl
Jun 6, 2006·Journal of Molecular Biology·Christofer LendelTorleif Härd
Jun 8, 2006·Journal of the American Chemical Society·Elisabet Wahlberg, Torleif Härd
Nov 8, 2006·Journal of Biotechnology·Caroline GrönwallNina Herne
Jan 6, 2007·Journal of Proteome Research·Björn RenbergAmelie Eriksson Karlström
Mar 3, 2007·Bioconjugate Chemistry·Thuy TranAmelie Eriksson Karlström
Mar 22, 2007·Expert Opinion on Biological Therapy·Vladimir TolmachevLars Abrahmsén
May 29, 2007·Oncogene·R Nahta, F J Esteva
Jun 15, 2007·European Journal of Nuclear Medicine and Molecular Imaging·Torun EngfeldtVladimir Tolmachev

❮ Previous
Next ❯

Citations

Dec 11, 2008·European Journal of Nuclear Medicine and Molecular Imaging·Vladimir TolmachevAnna Orlova
Jun 9, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Thuy A TranVladimir Tolmachev
Sep 23, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Anna OrlovaVladimir Tolmachev
Feb 5, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Vladimir TolmachevAnna Orlova
Nov 12, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Vladimir TolmachevAnna Orlova
Dec 16, 2011·European Journal of Nuclear Medicine and Molecular Imaging·Daniel RosikVladimir Tolmachev
Dec 2, 2011·Systems and Synthetic Biology·Vijaya Gopal, Kunchur Guruprasad
Aug 10, 2010·Acta Pharmacologica Sinica·Jing Li, Zhenping Zhu
Jan 1, 2010·Biotechnology & Genetic Engineering Reviews·R Cochran, Frank Cochran
Dec 19, 2009·Protein Engineering, Design & Selection : PEDS·Kelly Davis OrcuttK Dane Wittrup
Dec 18, 2013·Protein Engineering, Design & Selection : PEDS·Petra ZadravecAleš Berlec
May 23, 2013·Acta Crystallographica. Section D, Biological Crystallography·David W BannerArmin Ruf
Aug 31, 2010·Applied and Environmental Microbiology·Matjaz RavnikarAles Berlec
May 7, 2013·Annual Review of Biomedical Engineering·Scott BantaOren Shur
Jul 28, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rafal ZielinskiJacek Capala
Nov 1, 2008·BMC Biotechnology·Bertil MacaoTorleif Härd
Mar 19, 2011·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Seiji Shibasaki
Oct 13, 2011·PloS One·Johan NilvebrantJohn Löfblom
Mar 2, 2013·PloS One·Immacolata LuisiFederico Berti
Nov 10, 2011·Technology in Cancer Research & Treatment·Y ArdeshirpourA Gandjbakhche
Dec 25, 2013·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Jingjuan QiaoJenny J Yang
Apr 1, 2014·Biomacromolecules·Ronnie JanssonMy Hedhammar
Nov 26, 2009·Natural Product Reports·Matthew F Burton, Patrick G Steel
Feb 16, 2012·Bioorganicheskaia khimiia·L E PetrovskaiaM P Kirpichnikov
Feb 20, 2013·Chemical Society Reviews·Anthony P F Turner
Apr 13, 2013·Current Opinion in Structural Biology·Magdalena A Bukowska, Markus G Grütter
Jan 30, 2013·Nuclear Medicine and Biology·Hadis HonarvarPeter Järver
May 15, 2012·Journal of Proteomics·Alessio MaiolicaRuedi Aebersold
Nov 1, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·S Rahima BenhabbourRussell J Mumper

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.